Tus-Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 46.9% in First Quarter of 2023

Tus-Pharmaceutical Group Co.,Ltd. (启迪药业集团股份公司) (000590.SZ) reported a net profit of 6.6 million yuan in the first quarter of 2023, down 46.9% year-on-year.

Meanwhile, the company posted 101.2 million yuan in revenue, up 10.8% year-on-year.

At the end of the reporting period, it had 1.2 billion yuan in total assets and 451.8 million yuan in total liabilities, with a liability-to-asset ratio of 38.9%.